Test Price
1,700 AED✅ Home Collection Available
Limb-Girdle Muscular Dystrophy (LGMD) Comprehensive Genetic Panel in UAE | 1,700 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015‑certified Next‑Generation Sequencing, ensuring robust detection of pathogenic variants implicated in Limb‑Girdle Muscular Dystrophy.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM across all UAE emirates.
Clinical Guidance: Complimentary Telephonic Post‑Test Clinical Guidance with a DHA‑licensed specialist to interpret results and plan next steps.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced genetic panel screens for pathogenic variants in over 30 genes associated with Limb‑Girdle Muscular Dystrophy (LGMD), including CAPN3, DYSF, FKRP, SGCA, and ANO5. Designed for precision diagnosis and genetic counselling, it employs state‑of‑the‑art Next‑Generation Sequencing with copy‑number variant analysis to detect both point mutations and large deletions/duplications. Results empower neurologists, anti‑aging specialists, and clinical geneticists to tailor management and predict prognosis.
| Feature | Our LGMD Panel (UAE) | Closest Alternative |
|---|---|---|
| Methodology | NGS + MLPA (full gene coverage) – ISO 9001:2015 | Sanger sequencing (limited gene subset) |
| Diagnostic Yield | 99.9% sensitivity for known LGMD genes | ~80% (single‑gene tests) |
| Turnaround Time | 14–21 working days | 4–6 weeks |
*Comparison based on publicly available data; actual performance may vary.
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I view the LGMD Panel as a critical tool for early diagnosis and family planning. However, genetic variants must always be correlated with clinical findings; a positive result identifies susceptibility, not inevitability. Please consult your specialist before altering any treatment regimen.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication & Safety Guidance
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing clinical management. Abrupt cessation of therapy may cause harm. Always consult your physician before making any changes to your treatment plan based on genetic results.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria: Active skin infection or bleeding disorder at the blood collection site. Patients on anticoagulants require physician clearance before sample collection.
Emergency Red Flags: Seek immediate medical attention (call 998) if you experience sudden difficulty breathing, chest pain, rapid progression of muscle weakness, or loss of ability to swallow before or after testing.
Patient FAQ & Clinical Guidance
1. What is Limb‑Girdle Muscular Dystrophy and how is it diagnosed with this test?
Limb‑Girdle Muscular Dystrophy (LGMD) is a group of genetic disorders causing progressive muscle weakness around the hips and shoulders. Our LGMD Panel analyzes blood DNA using Next‑Generation Sequencing to detect disease‑causing mutations with 99.9% sensitivity, providing definitive diagnostic confirmation in symptomatic individuals. Results are interpreted by our clinical geneticist and reported in 14–21 days.
2. Can I book a home collection for the LGMD test in Dubai or Abu Dhabi?
Yes, we offer VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection across all UAE emirates, available daily from 8 AM to 11 PM, with ISO‑certified transport to our central laboratory. Contact us on WhatsApp to schedule your appointment.
3. How should I prepare for the test and are there any medication restrictions?
No fasting or special preparation is required; continue all prescribed medications unless advised otherwise by your physician, as abrupt discontinuation could be harmful. Genetic testing does not interfere with daily routines or diet.
UAE Regulatory & Data Privacy Adherence
Your personal and genetic data are protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE adheres to all DHA regulatory standards forgenetic testing and data handling.
Clinical & Logistical Metadata
| Test Name | Limb-Girdle Muscular Dystrophy (LGMD) Comprehensive Genetic Panel |
| Price (AED) | 1,700 AED |
| Turnaround Time | 14–21 Working Days |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (NGS) + MLPA |
| ICD-10-CM Code | G71.09 |
| LOINC Code | 69047-9 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians